Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
Ther Innov Regul Sci ; 52(1): 62-69, 2018 01.
Article in English | MEDLINE | ID: mdl-29714608

ABSTRACT

The medical device industry is an industry dealing with multiple types of products covering a wide range of applications. As the safety and effectiveness of medical devices are vital to human health, the products must be managed by strict regulations according to the different risk levels. A total product life cycle regulatory system including product design, manufacture, premarket gate keeping, and postmarket monitoring is a common framework for medical device regulations. However, the variety and innovativeness of medical devices are challenging the current regulatory frameworks. Hence, the competent authorities responsible for medical devices worldwide keep renewing their regulatory systems to ensure the safety and effectiveness of medical devices. This review aims to provide an informative review of the regulatory frameworks of medical devices in the United States, Europe, Canada, and Taiwan, with a particular focus on updated regulatory changes in these countries and the current status of global harmonization on medical devices.


Subject(s)
Medical Device Legislation , Canada , Device Approval , Europe , Product Surveillance, Postmarketing , Quality Control , Taiwan , United States
2.
J Nat Prod ; 76(3): 405-12, 2013 Mar 22.
Article in English | MEDLINE | ID: mdl-23305495

ABSTRACT

The N-homologues and optical isomers of thaliporphine (5a), a potent antiarrhythmic agent, were prepared starting from laurolitsine (1), an abundant aporphine present in Phoebe formosana. Treating N-propylnorglaucine with 90% H2SO4 yielded one additional product, an 11-sulfonyl-1,11-anhydroaporphine. Reaction of N-formylnorglaucine (3a) with 90% H2SO4, however, yielded the 9-sulfonyl-seco product as a major product. Treatment of 3a with 98% H2SO4 yielded pancordine (10), which, upon catalytic hydrogenation, yielded (±)-wilsonirine. (1)H NMR spectroscopic analysis was applied successfully to monitor the optical purity of the crystalline salt while undertaking optical resolution. Thaliporphine (5a) was demonstrated to possess better positive inotropic and less negative chronotropic effects than the left-hand optical isomer and showed the best activity on rat cardiac tissue among the N-homologues prepared.


Subject(s)
Anti-Arrhythmia Agents/pharmacology , Aporphines/pharmacology , Animals , Anti-Arrhythmia Agents/chemical synthesis , Anti-Arrhythmia Agents/chemistry , Aporphines/chemical synthesis , Aporphines/chemistry , Heart/drug effects , Molecular Structure , Nuclear Magnetic Resonance, Biomolecular , Rats , Stereoisomerism
SELECTION OF CITATIONS
SEARCH DETAIL
...